Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2020, Vol. 25 ›› Issue (5): 527-532.doi: 10.12092/j.issn.1009-2501.2020.05.007

Previous Articles     Next Articles

miR-106a regulates the proliferation of ovarian granulosa cells by targeting TIMP-2

OU Jun1, HOU Wenwen1, TANG Jingwen1, LI Jiaping2, XU Qingyang1   

  1. 1 Center of Reproductive Medicine, Yijishan Hospital of Wannan Medical College, Wuhu 241000, Anhui, China;
    2 Department of Thoracic Surgery, Yijishan Hospital of Wannan Medical College, Wuhu 241000, Anhui, China
  • Published:2020-07-06

Abstract: AIM: To investigate the regulation function of miR-106a on the proliferation of human ovarian granulosa cells, and to explore its possible target. METHODS: The expression of miR-106a in granulosa cells was regulated by cell transfection, and its expression level was detected by RT-PCR. The MTT assay was used to detect the cell proliferation activities of cells. Bioinformatics methods were used to predicted the possible target genes of miR-106a, which were verified them by double-luciferase assay. The expression of target protein was detected by Western blot. RESULTS: The expression of miR-106a in KGN cells was significantly higher than that of normal ovarian epithelial cell (IOSE80), the difference was statistically significant (P<0.05). The proliferation activity of KGN cells was significantly decreased after inhibiting the expression of miR-106a (P<0.05). The results of dual luciferase assay showed that miR-106a could directly target TIMP-2 gene. Western blot results showed that the expression level of TIMP-2 protein was significantly decreased after overexpression of miR-106a (P<0.05). CONCLUSION: miR-106a can promote the proliferation of KGN cell; The mechanism is related to the targeted reduction of TIMP-2 expression level.

Key words: miR-106a, TIMP-2, proliferation, ovarian granulosa cells, polycystic ovary syndrome

CLC Number: